Skip to main content
. 2021 Mar 8;33(2):138–146. doi: 10.5021/ad.2021.33.2.138

Table 3. Comparison between psoriasis and control groups according to AHR and CYP1A1 expression.

Variable Psoriasis group (n=24) Control group (n=10) p-value
AHR expression
 Intensity <0.001*
  None 0 (0) 7 (70.0)
  Mild 3 (12.5) 3 (30.0)
  Moderate 9 (37.5) 0 (0)
  Strong 12 (50.0) 0 (0)
 Distribution <0.001*
  Negative 0 (0) 7 (70.0)
  Basal 1 (4.2) 0 (0)
  Both basal and suprabasal 21 (87.5) 3 (30.0)
  Full thickness 2 (8.3) 0 (0)
CYP1A1 expression
 Intensity <0.001*
  None 0 (0) 6 (60.0)
  Mild 0 (0) 4 (40.0)
  Moderate 7 (29.2) 0 (0)
  Strong 17 (70.8) 0 (0)
 Distribution <0.001*
  Negative 0 (0) 6 (60.0)
  Basal 0 (0) 0 (0)
  Both basal and suprabasal 17 (70.8) 4 (40.0)
  Full thickness 7 (29.2) 0 (0)

Values are presented as number (%). AHR: aryl hydrocarbon receptor. *p<0.05.